Open Access

Future direction for research in drug therapy.

Congress Session

About the speaker

Professor John R Teerlink

San Francisco Veterans Affairs Medical Center, San Francisco (United States of America)
18 presentations
0 follower

4 more presentations in this session

State of the art in drug therapy in chronic heart failure.

Speaker: Professor D. van Veldhuisen (Groningen, NL)

Thumbnail

Mortality and morbidity in heart failure patients exposed to Digoxin: comprehensive data according to ejection fraction and atrial fibrillation in 41881 patients from the Swedish Heart Failure Registr

Speaker: Doctor G. Savarese (Stockholm, SE)

Thumbnail

Beneficial effect of aldosterone antagonism on exercise tolerance in heart failure with preserved ejection fraction- SpironolacTone in myocaRdial dysfUnCTion with redUced exeRcisE capacity (STRUCTURE)

Speaker: Professor W. Kosmala (Wroclaw, PL)

Thumbnail

Risk of long-term mortality associated with diuretic treatment in 17,519 heart failure outpatients was increased with 42% after adjustment for MAGGIC mortality risk predictors

Speaker: Doctor P. Paren (Mölndal, SE)

Thumbnail

Access the full session

Drug therapy in heart failure

Speakers: Professor J. Teerlink, Professor D. van Veldhuisen, Doctor G. Savarese, Professor W. Kosmala, Doctor P. Paren
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk